What happened?
Calithera Biosciences(NASDAQ:CALA), a clinical-stage biotech company, reported on Monday morning that telaglenastat, one of its leading pipeline candidates, flopped in a clinical tria… [+1639 chars]
Rapid Voice News
Exclusive
Breaking News RVN
English
Arabic
Chinese (Simplified)
French
German
Hebrew
Italian
Japanese
Korean
Portuguese
Romanian
Russian
Spanish
More Stories
‘Pivoting’: Fox Boss Calls Canceling Comedy After One Season A “Tough Call” & Hints At Business Reasons – Deadline
Jason Momoa dating Eiza González after Lisa Bonet breakup: report – Page Six
Fox Has Just One Regret About Giuliani Appearing on The Masked Singer… – TVLine